| 货号 | 1692/10 |
| 别名 | 6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl |
| 供应商 | Tocris |
| 生物活性 | Potent phosphodiesterase III A (PDE3A) inhibitor (IC50 = 0.2 μM) and inhibitor of adenosine uptake. Has antimitogenic, antithrombotic, vasodilatory and cardiotonic properties in vivo. Also affects lipid levels in vivo. |
| 运输条件 | Blue Ice |
| 存放说明 | Ambient |
| 纯度 | >99 % |
| 计算分子量 | 369.47 |
| 分子式 | C20H27N5O2 |
| 可溶性/溶解性 | Soluble to 10 mM in ethanol and to 50 mM in DMSO |
| CAS号 | 73963-72-1 |
| 参考文献 | Schror (2002) The pharmacology of cilostazol. Diabetes Obes.Metab. 4 S14. PMID: 12180353. Shintaniet al (1985) General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: effects on the central nervous system. Arzneimittelforschung 35 1157. PMID: 4074429. Shintaniet al (1985) General pharmacological properties of cilostazol, a new antithrombotic drug. Part II: effects on the peripheral organs. Arzneimittelforschung 35 1163. PMID: 3000392. |